Zanidatamab (Zani) Plus Chemotherapy (Chemo) And Tislelizumab (Tis) As First-Line (1L) Therapy For Patients (Pts) With Advanced Her2-Positive (+) Gastric/Gastroesophageal Junction Adenocarcinoma (Gc/Gejc): Updated Results From A Phase Ib/II Study
Tislelizumab;Zanidatamab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Zanidatamab (Zani) Plus Chemotherapy (Chemo) And Tislelizumab (Tis) As First-Line (1L) Therapy For Patients (Pts) With Advanced Her2-Positive (+) Gastric/Gastroesophageal Junction Adenocarcinoma (Gc/Gejc): Updated Results From A Phase Ib/II Study ### Output: Tislelizumab;Zanidatamab